Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 19/20 | 0.76 |
| ▸ | CCKAR | P32238 | 3/20 | 0.75 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29369750 | 0.95 | CCKBR (0.82) | CCKBRCCKAROPRD1 | |
| SCHEMBL29408692 | 0.95 | CCKBR (0.74) | CCKBRCCKAROPRD1 | |
| SCHEMBL29367056 | 0.94 | CCKBR (0.73) | CCKBRCCKAROPRD1 | |
| SCHEMBL32667710 | 0.94 | CCKBR (0.78) | CCKBRCCKAROPRD1 | |
| SCHEMBL30887334 | 0.92 | CCKBR (0.71) | CCKBRCCKAROPRD1 | |
| SCHEMBL31015845 | 0.92 | CCKBR (0.82) | CCKBRCCKAROPRD1 | |
| SCHEMBL30951444 | 0.92 | CCKBR (0.82) | CCKBRCCKAROPRD1 | |
| SCHEMBL29833626 | 0.91 | CCKBR (0.76) | CCKBRCCKAR | |
| SCHEMBL30887325 | 0.91 | CCKBR (0.70) | CCKBRCCKAROPRD1 | |
| SCHEMBL30533211 | 0.91 | CCKBR (0.83) | CCKBRCCKAROPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4631959-A2 | NOVEL MINIGASTRIN-DERIVED CHOLECYSTOKININ 2 RECEPTOR BINDING MOLECULES FOR IMAGING AND TARGETED RADIOTHERAPY | Technische Universität München, in Vertretung des Freistaates Bayern (DE) | 2025-10-15 | — | — | EP | claimed |
| EP-4590347-A1 | NOVEL MINIGASTRIN-DERIVED CHOLECYSTOKININ 2 RECEPTOR BINDING MOLECULES FOR IMAGING AND TARGETED RADIOTHERAPY | Technische Universität München (DE) | 2025-07-30 | — | — | EP | claimed |
| CN-119907695-A | Novel small gastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy | 慕尼黑工业大学 | 2025-04-29 | — | — | CN | claimed |
| EP-4409040-A1 | METHOD FOR PREDICTING THE RESPONSE OF A PATIENT DIAGNOSED WITH CANCER TO TREATMENT AND/OR IMAGING WITH A COMPOUND TARGETING CCK2-R, AND COMPOUND FOR USE IN METHODS OF SELECTIVELY TREATING AND/OR IMAGING CANCER | Paul Scherrer Institut (CH) | 2024-08-07 | — | — | EP | claimed |
| EP-3684395-B1 | MINIGASTRIN DERIVATES, IN PARTICULAR FOR USE IN CCK2 RECEPTOR POSITIVE TUMOUR DIAGNOSIS AND/OR TREATMENT | SCHERRER INST PAUL (CH) | 2024-06-19 | — | — | EP | claimed |
| WO-2024061483-A1 | NOVEL MINIGASTRIN-DERIVED CHOLECYSTOKININ 2 RECEPTOR BINDING MOLECULES FOR IMAGING AND TARGETED RADIOTHERAPY | Technische Universität München (DE) | 2024-03-28 | — | — | WO | claimed |
| EP-4188454-A1 | GALLIUM-LABELED GASTRIN ANALOGUE AND USE IN A METHOD OF IMAGING CCKB-RECEPTOR-POSITIVE TUMORS OR CANCERS | Paul Scherrer Institut (CH) | 2023-06-07 | — | — | EP | claimed |
| WO-2023051897-A1 | METHOD FOR PREDICTING THE RESPONSE OF A PATIENT DIAGNOSED WITH CANCER TO TREATMENT AND/OR IMAGING WITH A COMPOUND TARGETING CCK2-R, AND COMPOUND FOR USE IN METHODS OF SELECTIVELY TREATING AND/OR IMAGING CANCER | DEBIOPHARM INTERNATIONAL S.A. (CH) | 2023-04-06 | — | — | WO | claimed |
| WO-2022023539-A1 | GALLIUM-LABELED GASTRIN ANALOGUE AND USE IN A METHOD OF IMAGING CCKB-RECEPTOR-POSITIVE TUMORS OR CANCERS | DEBIOPHARM INTERNATIONAL S.A. (CH) | 2022-02-03 | — | — | WO | claimed |
| EP-4631959-A3 | NOVEL MINIGASTRIN-DERIVED CHOLECYSTOKININ 2 RECEPTOR BINDING MOLECULES FOR IMAGING AND TARGETED RADIOTHERAPY | Technische Universität München, in Vertretung des Freistaats Bayern (DE) | 2025-12-17 | — | — | EP | disclosed |
| EP-4631959-A2 | NOVEL MINIGASTRIN-DERIVED CHOLECYSTOKININ 2 RECEPTOR BINDING MOLECULES FOR IMAGING AND TARGETED RADIOTHERAPY | Technische Universität München, in Vertretung des Freistaates Bayern (DE) | 2025-10-15 | — | — | EP | disclosed |
| EP-4631959-A2 | NOVEL MINIGASTRIN-DERIVED CHOLECYSTOKININ 2 RECEPTOR BINDING MOLECULES FOR IMAGING AND TARGETED RADIOTHERAPY | Technische Universität München, in Vertretung des Freistaates Bayern (DE) | 2025-10-15 | — | — | EP | disclosed |
| EP-4619411-A1 | DUAL RECEPTOR TARGETING RADIOLIGANDS AND USES THEREOF | Full-Life Technologies HK Limited (HK) | 2025-09-24 | — | — | EP | disclosed |
| EP-4590347-A1 | NOVEL MINIGASTRIN-DERIVED CHOLECYSTOKININ 2 RECEPTOR BINDING MOLECULES FOR IMAGING AND TARGETED RADIOTHERAPY | Technische Universität München (DE) | 2025-07-30 | — | — | EP | disclosed |
| EP-4188456-A1 | ALPHA RADIOLABELED GASTRIN ANALOGUE AND USE THEREOF IN METHODS OF TREATING CCKB RECEPTOR POSITIVE DISEASE | PAUL SCHERRER INSTITUT (CH) | 2023-06-07 | — | — | EP | disclosed |
| EP-4188455-A1 | COMPOSITION COMPRISING A RAPALOG AND A RADIOLABELLED GASTRIN ANALOGUE, IN PARTICULAR FOR USE IN THE TREATMENT AND/OR DIAGNOSIS OF CCKB RECEPTOR POSITIVE CANCER OR TUMORS | PAUL SCHERRER INSTITUT (CH) | 2023-06-07 | — | — | EP | disclosed |
| WO-2023051897-A1 | METHOD FOR PREDICTING THE RESPONSE OF A PATIENT DIAGNOSED WITH CANCER TO TREATMENT AND/OR IMAGING WITH A COMPOUND TARGETING CCK2-R, AND COMPOUND FOR USE IN METHODS OF SELECTIVELY TREATING AND/OR IMAGING CANCER | DEBIOPHARM INTERNATIONAL S.A. (CH) | 2023-04-06 | — | — | WO | disclosed |
| WO-2022023541-A1 | COMPOSITION COMPRISING A RAPALOG AND A RADIOLABELLED GASTRIN ANALOGUE, IN PARTICULAR FOR USE IN THE TREATMENT AND/OR DIAGNOSIS OF CCKB RECEPTOR POSITIVE CANCER OR TUMORS | PAUL SCHERRER INSTITUT (CH) | 2022-02-03 | — | — | WO | disclosed |
| WO-2022023554-A1 | ALPHA RADIOLABELED GASTRIN ANALOGUE AND USE THEREOF IN METHODS OF TREATING CCKB RECEPTOR POSITIVE DISEASE | PAUL SCHERRER INSTITUT (CH) | 2022-02-03 | — | — | WO | disclosed |
| WO-2022023539-A1 | GALLIUM-LABELED GASTRIN ANALOGUE AND USE IN A METHOD OF IMAGING CCKB-RECEPTOR-POSITIVE TUMORS OR CANCERS | DEBIOPHARM INTERNATIONAL S.A. (CH) | 2022-02-03 | — | — | WO | disclosed |